Ligustrazine phosphoric acid sustained-release dropping pill and preparation method thereof
A technology of ligustrazine phosphate and sustained-release dropping pills is applied in the directions of pharmaceutical formulations, medical preparations containing active ingredients, drug delivery, etc., which can solve the problems of difficult operation and great pain for patients, and achieves low labor intensity and simple equipment. , the effect of less process
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0040] Based on the total weight of 100g, weigh 30% of the matrix PEG4000, 10% of PEG6000, 33% of stearic acid, and 27% of the raw material ligustrazine phosphonate; it is prepared according to the above method.
[0041] The obtained product has qualified release degree and good roundness.
Embodiment 2
[0043] Based on the total weight of 100g, weigh 40% of the matrix PEG4000, 15% of PEG6000, 35% of stearic acid, and 10% of the raw material ligustrazine phosphonate; it is prepared according to the above method.
[0044] The release degree is qualified and the roundness is good.
Embodiment 3
[0046] Based on the total weight of 100g, weigh 20% of the base polyoxyl (40) stearate, 10% of PEG6000, 43% of glyceryl monostearate, and 27% of the raw material ligustrazine phosphonate; prepared by the above method.
[0047] The obtained product has qualified release degree and good roundness.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com